Gw&K Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History

Gw&K Investment Management, LLC

$11.7 Billion
Q3 2024

A detailed history of Gw&K Investment Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,762,261 shares of HALO stock, worth $86.4 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

1,762,261

Previous 2,180,005 19.16%

Holding current value

$86.4 Million

Previous $114 Million 11.63%

% of portfolio

0.86%

Previous 1.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$51.3 - $64.42 $21.4 Million - $26.9 Million	-417,744 Reduced 19.16%	1,762,261 $101 Million
Q2 2024 Aug 12, 2024	SELL	$37.81 - $52.4 $637,930 - $884,092	-16,872 Reduced 0.77%	2,180,005 $114 Million
Q1 2024 May 08, 2024	SELL	$33.68 - $41.95 $998,982 - $1.24 Million	-29,661 Reduced 1.33%	2,196,877 $89.4 Million
Q4 2023 Feb 09, 2024	SELL	$33.32 - $42.1 $3.92 Million - $4.96 Million	-117,767 Reduced 5.02%	2,226,538 $82.3 Million
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $1.29 Million - $1.55 Million	-35,284 Reduced 1.48%	2,344,305 $89.6 Million
Q2 2023 Aug 09, 2023	SELL	$30.28 - $38.74 $682,087 - $872,657	-22,526 Reduced 0.94%	2,379,589 $85.8 Million
Q1 2023 May 09, 2023	BUY	$32.86 - $55.7 $10.3 Million - $17.4 Million	313,259 Added 15.0%	2,402,115 $91.7 Million
Q4 2022 Feb 10, 2023	SELL	$40.06 - $59.44 $4.57 Million - $6.79 Million	-114,186 Reduced 5.18%	2,088,856 $119 Million
Q3 2022 Nov 09, 2022	BUY	$38.53 - $51.78 $21.6 Million - $29 Million	559,654 Added 34.05%	2,203,042 $87.1 Million
Q2 2022 Aug 09, 2022	SELL	$37.35 - $48.3 $391,091 - $505,749	-10,471 Reduced 0.63%	1,643,388 $72.3 Million
Q1 2022 May 09, 2022	BUY	$31.97 - $41.06 $3.04 Million - $3.91 Million	95,215 Added 6.11%	1,653,859 $66 Million
Q4 2021 Feb 11, 2022	BUY	$31.82 - $40.75 $1.91 Million - $2.44 Million	59,875 Added 3.99%	1,558,644 $62.7 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $16.8 Million - $20.2 Million	435,575 Added 40.97%	1,498,769 $61 Million
Q2 2021 Aug 10, 2021	BUY	$38.84 - $51.31 $76,281 - $100,772	1,964 Added 0.19%	1,063,194 $48.3 Million
Q1 2021 May 11, 2021	BUY	$39.51 - $51.45 $8.65 Million - $11.3 Million	218,975 Added 26.0%	1,061,230 $44.2 Million
Q4 2020 Feb 05, 2021	BUY	$25.81 - $43.62 $21.7 Million - $36.7 Million	842,255 New	842,255 $36 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.83B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gw&K Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gw&K Investment Management, LLC with notifications on news.

Account

Gw&K Investment Management, LLC Halozyme Therapeutics, Inc. Transaction History